GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » Net Margin %

Anti-Microbialvior BioteQ Co (ROCO:6864) Net Margin % : -16,189.64% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Anti-Microbialvior BioteQ Co's Net Income for the six months ended in Dec. 2023 was NT$-31.25 Mil. Anti-Microbialvior BioteQ Co's Revenue for the six months ended in Dec. 2023 was NT$0.19 Mil. Therefore, Anti-Microbialvior BioteQ Co's net margin for the quarter that ended in Dec. 2023 was -16,189.64%.

The historical rank and industry rank for Anti-Microbialvior BioteQ Co's Net Margin % or its related term are showing as below:

ROCO:6864' s Net Margin % Range Over the Past 10 Years
Min: -25398.86   Med: -13124.95   Max: -1176.75
Current: -7112.91


ROCO:6864's Net Margin % is ranked worse than
89.02% of 1020 companies
in the Biotechnology industry
Industry Median: -152.785 vs ROCO:6864: -7112.91

Anti-Microbialvior BioteQ Co Net Margin % Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co Net Margin % Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial - -19,136.99 -25,398.86 -1,176.75 -7,112.91

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only -14,703.41 -912.24 -1,454.33 -3,838.50 -16,189.64

Competitive Comparison of Anti-Microbialvior BioteQ Co's Net Margin %

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's Net Margin % falls into.



Anti-Microbialvior BioteQ Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Anti-Microbialvior BioteQ Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-51.782/0.728
=-7,112.91 %

Anti-Microbialvior BioteQ Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-31.246/0.193
=-16,189.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Anti-Microbialvior BioteQ Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co (ROCO:6864) Business Description

Traded in Other Exchanges
N/A
Address
Sec.1, Huandong Road, 1 Floor, No. 2, Ln. 31, Xinshi District, Tainan, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co (ROCO:6864) Headlines

No Headlines